Efficacy of gabapentin enacarbil in adult patients with severe primary restless legs syndrome.


AIM Assess efficacy and tolerability of gabapentin enacarbil (GEn) in adults with severe primary restless legs syndrome (RLS). METHODS We pooled data from three 12-week, double-blind, placebo-controlled, randomized trials (NCT00298623, NCT00365352, NCT01332305) across GEn 600-mg, GEn 1200-mg, and placebo treatment groups for severe primary RLS (baseline… (More)
DOI: 10.1016/j.sleep.2015.11.002